Clinical Scorecard: Evaluating the Effectiveness of a 'Stage-Gated' Method for Prostate Screening MRI Reporting: "Can Less Be More?"
At a Glance
Category
Detail
Condition
Prostate cancer (PCa)
Key Mechanisms
Use of biparametric MRI (bpMRI) with a two-step 'stage-gated' reporting approach to improve positive predictive value (PPV) and reduce unnecessary biopsies in prostate cancer screening
Target Population
Men aged 50–69 years with life expectancy ≥ 10 years, without recent PSA testing, prostate MRI, biopsy, or prostate cancer history
Care Setting
Population-based prostate cancer screening programs using MRI and PSA testing
Key Highlights
Conventional MRI scoring systems (Likert/PI-RADS) have limited PPV (27%-46%) in low-prevalence screening populations, leading to unnecessary biopsies.
The 'stage-gated' approach uses initial limited bpMRI sequences (axial T2WI and high b-value DWI) reviewed by multiple radiologists to identify screen-positive cases.
Advancement to full bpMRI review and biopsy recommendation is based on consensus or elevated PSA density, balancing specificity and sensitivity.
Guideline-Based Recommendations
Diagnosis
Use biparametric MRI sequences (axial T2WI and high b-value DWI) as initial screening step in prostate cancer screening.
Apply a two-step 'stage-gated' reporting approach with multiple expert readers to classify scans as screen-positive, screen-negative, or non-diagnostic.
Incorporate PSA density (≥ 0.12 ng/mL2) to decide advancement to full bpMRI review in discordant cases.
Management
Recommend biopsy for scans scoring PI-RADS ≥ 4 or PI-RADS 3 with elevated PSA density after full bpMRI review.
Use transperineal systematic 12-core biopsies with additional image fusion–targeted biopsies for screen-positive cases.
Monitoring & Follow-up
Radiologists should be blinded to clinical and pathological data during MRI interpretation to reduce bias.
Repeat scans with poor image quality and manage artefacts (e.g., rectal gas) to ensure diagnostic quality.
Risks
Potential for unnecessary biopsies due to low PPV of conventional MRI scoring in screening populations.
Risk of non-diagnostic scans requiring additional imaging or follow-up.
Patient & Prescribing Data
Men aged 50–69 years undergoing prostate cancer screening without prior recent PSA or MRI testing
The 'stage-gated' MRI reporting method may reduce unnecessary biopsies by improving PPV while maintaining sensitivity, potentially minimizing treatment-related harms.
Clinical Best Practices
Implement a two-step MRI reporting workflow with initial limited sequence review followed by full bpMRI assessment if criteria met.
Use consensus reading among multiple expert radiologists to improve specificity in screening MRI interpretation.
Incorporate PSA density thresholds to guide further imaging review and biopsy decisions.
Ensure MRI acquisition protocols include axial and sagittal T2WI and multiple b-value DWI sequences for comprehensive assessment.
Maintain blinding of radiologists to clinical data to reduce interpretation bias.
by Natasha Thorley, Tom Parry, Giorgio Brembilla, Francesco Giganti, Tristan Barrett, David Eldred-Evans, Nikhil Mayor, Alistair Lamb, Penny L. Hubbard Cristinacce, Fiona Gong, Henry H. Tam, Heminder K. Sokhi, Anwar R. Padhani, Caroline M. Moore, David Atkinson, Hashim U. Ahmed, Shonit Punwani
With its combination of UWF imaging, OCT integration, and intelligent review tools, the MonacoPro represents the next step in comprehensive retinal evaluation. By improving image quality, enhancing diagnostic confidence, and streamlining workflow, the system supports clinicians in delivering more efficient, informed, and patient-centered care.
International study of more than 19,000 patients finds substantial differences in radiation exposure from coronary artery disease imaging across modalities, regions, and income levels.
